Jessica Ritsick, Yifan Wang, Ph.D. Our FDA: Drug & Device Team analyzes the Food and Drug Administration’s new guidance on Bayesian approaches to innovative drug trials, providing greater clarity on ...
A Bayesian re-analysis of hundreds of published clinical trials shows that statistically negative studies can hide strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results